Abs 0419 SELECT-AXIS 2, UPA improved outcomes vs PBO in nr-axSpA pts across all BL inflammation subgroups; greatest benefit obs in pts with both elevated CRP and inflammation on baseline MRI. #ACR22 @RheumNow https://t.co/opaFwXgcvU https://t.co/o27ULcL8Ip
Links:
Efficacy of Upadacitinib in Patients with Non-Radiographic Axial Spondyloarthri…
http://ow.ly/rLrY50LvusL
12-11-2022